n/a
Abstract Title:

Puerarin ameliorates hyperglycemia in HFD diabetic mice by promotingβ-cell neogenesis via GLP-1R signaling activation.

Abstract Source:

Phytomedicine. 2020 Apr 25 ;70:153222. Epub 2020 Apr 25. PMID: 32361558

Abstract Author(s):

Chunjun Wang, Jihong Yao, Linjie Ju, Xiaohua Wen, Luan Shu

Article Affiliation:

Chunjun Wang

Abstract:

BACKGROUND: Diabetes is characterized byβ-cell loss and dysfunction. A strategy for diabetes treatment is to promote new β-cell formation. Puerarin is an isoflavone from the root of Pueraria lobata (Willd.) Ohwi. Our previous study demonstrated puerarin could ameliorate hyperglycemia in diabetic mice. However, related mechanisms and potential roles of puerarin in β-cell neogenesis have not been elucidated.

PURPOSE: The present study aims to investigate whether anti-diabetic effect of puerarin is dependent on promotingβ-cell neogenesis via GLP-1R signaling activation.

METHODS: A high-fat diet (HFD) induced diabetic mouse model was applied to investigate effects of puerarin in vivo, exendin-4 (GLP-1R agonist) and metformin were used as positive controls. Moreover, related mechanisms and GLP-1R downstream signal transduction were explored in isolated cultured mouse pancreatic ductal cells.

RESULTS: Puerarin improved glucose homeostasis in HFD diabetic mice significantly. Markers of newβ-cell formation (insulin, PDX1 and Ngn3) were observed in pancreatic ducts of HFD mice treated by puerarin. Of note, efficacy of puerarin in vivo was suppressed by GLP-1R antagonist exendin9-39, but enhanced by exendin-4 respectively. In cultured mouse pancreatic ductal cells, puerarin induced expressions of insulin and PDX1, upregulated GLP-1R expression and activated β-catenin and STAT3 subsequently. Expressions of insulin and PDX1 in ductal cells could be blocked by exendin9-39, or β-catenin inhibitor ICG001, or JAK2 inhibitor AG490.

CONCLUSION: These data clarified puerarin ameliorated hyperglycemia of HFD mice via a novel mechanism involved promotingβ-cell neogenesis. Our finding highlights the potential value of puerarin developing as an anti-diabetic agent.

Study Type : Animal Study
Additional Links

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.